Hormone Replacement Therapy Market Share and Growth | 2031
激素替代疗法市场预测可以帮助该市场的利益相关者概述其增长战略。市场预计将从 2023 年的 84.6 亿美元增长到 2031 年的 148.2 亿美元;预计 2023-2031 年的复合年增长率为 7.3%。
由于激素紊乱患病率不断上升、人们对激素缺乏的认识不断提高以及 HRT 配方的改进等因素,全球对激素替代疗法 (HRT) 的需求正在稳步上升。由于其明显的安全性和有效性优势,生物同质激素替代疗法 (BHRT) 比合成激素更受欢迎。由于 BHRT 来自天然来源,因此人们认为它与人体自然产生的激素更为相似。
制药公司正在投资开发新型激素治疗配方,包括透皮贴剂、凝胶、乳膏和皮下植入物,以提高患者的便利性、依从性和安全性。这一因素推动了激素替代疗法市场的增长。2023 年 8 月,美国食品药品监督管理局 (FDA) 批准了 ANI Pharmaceuticals 的 0.1% 雌二醇凝胶简化新药申请。参考上市药物 Divigel 是一种雌激素激素疗法,用于治疗与更年期相关的中度至重度血管舒缩症状。 Divigel 的通用形式是雌二醇凝胶,浓度为 0.1%。
增长动力:
广泛的应用推动激素替代疗法市场增长
激素替代疗法用于治疗更年期症状、生长激素缺乏症等,这些症状会对人的生活产生深远影响。数百万女性使用 HRT,有时甚至使用很长时间。HRT 可以通过多种方式预防骨质疏松症并改善生活质量。根据俄勒冈健康与科学大学的数据,生长激素缺乏症 (GHD) 并不常见,它影响美国大约 50,000 名成年人和大约每 4,000 到 6,000 名儿童中就有 1 名患有该病。因此,该疗法的使用率不断提高,再加上各种激素紊乱的患病率不断上升,推动了激素替代疗法治疗市场的增长。
限制:
药物成本高阻碍激素替代疗法市场的增长
HRT 产品的成本相对较高。例如,根据更年期中心的数据,口服激素替代疗法处方的价格为每月 130 至 240 美元(即每年 1,560 至 2,440 美元)。高昂的成本阻碍了这些产品的常规使用,从而限制了激素替代疗法市场的增长。
报告细分和范围:
激素替代疗法市场分析是通过考虑以下细分进行的:治疗、应用、给药途径和最终用户。
根据治疗方法,激素替代疗法市场细分为雌激素替代、生长激素替代、甲状腺激素替代、睾酮替代等。雌激素替代部分在 2023 年占据了最大的市场份额。
激素替代疗法 市场按应用分为更年期、生长激素 (GH) 缺乏、甲状腺功能减退、性腺功能减退等。更年期领域在 2023 年占据了激素替代疗法市场份额的最大部分,预计在预测期内将实现最高的复合年增长率。
区域分析:
就地区而言,激素替代疗法市场报告的范围包括北美、欧洲、亚太地区、南美和中美洲以及中东和非洲。2023 年,北美占据了最大的市场份额。最新技术的日益普及、激素紊乱患病率的上升、新产品的早期采用以及主要市场参与者的存在,都推动了北美激素替代疗法市场规模的不断增长。根据辉瑞公司和OPKO Health Inc.发布的声明,2023年6月,每周使用一次的人类生长激素类似物NGENLA(somatrogon-ghla)获得美国食品药品监督管理局(FDA)批准,用于治疗因内源性生长激素分泌不足导致生长障碍的三岁及以上儿科患者。
此外,在预测期内,更加注重提供优质个性化护理的机会并加强医疗保健解决方案,将为激素替代疗法市场创造重大机遇。 2023 年 5 月,德克萨斯州最大的激素替代诊所网络之一 Hormones by Design 被 Forum Health, LLC 收购,后者是第一家全国性的综合和功能医学提供商网络。
行业发展和未来机遇:
根据公司新闻稿,激素替代疗法市场领先企业的战略发展如下:
- •2024 年 1 月,丹麦 Ascendis Pharma A/S 和 Vector Pharma FZCO (Vector) 达成独家分销协议,负责在海湾合作委员会 (GCC) 国家沙特阿拉伯、阿联酋、科威特、阿曼、卡塔尔和巴林商业化 Yorvipath 和 Skytrofa。根据该独家经销协议的条款,Vector 将利用其销售和营销经验,为 GCC 国家的患者提供 Yorvipath 和 Skytrofa,用于治疗成人甲状旁腺功能减退症(Yorvipath 治疗)和儿童生长激素缺乏症 (GHD)(Skytrofa 治疗)。
竞争格局和主要公司:
阿斯利康;辉瑞公司;诺华公司;雅培;Tolmar Inc;Par Pharmaceutical;Mayne Pharma Group Limited;Novo Nordisk A/S;Eli Lily and Company;以及 Noven Pharmaceuticals, Inc. 是激素替代疗法市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品和扩大其地理覆盖范围,以满足全球日益增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
By therapy, the market is segmented into estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, testosterone replacement, and others. The estrogen hormone replacement segment held a larger hormone replacement therapy market share in 2023.
Increasing use of hormone replacement therapy products and increasing prevalence of hormone disorder propel the hormone replacement therapy market growth. However, high cost of medications hampers the growth of the market.
The hormone replacement therapy market majorly consists of the players, including Astrazeneca, Pfizer Inc., Novartis AG, Abbott, Tolmar Inc, Par Pharmaceutical, Mayne Pharma Group Limited, Novo Nordisk A/S, Eli Lily And Company, and Noven Pharmaceuticals, Inc.
Medication that contains female hormones is known as hormone replacement treatment. When you go through menopause, your body stops producing estrogen, so you take medication to replace it. The most common menopausal symptoms that hormone therapy is used to treat are hot flashes and vaginal discomfort.
The market, by distribution channel, is categorized into menopause, growth hormone (GH) deficiency, hypothyroidism, hypogonadism, and others. The menopause segment held the largest menopause market share in 2023, and it is anticipated to register the highest CAGR during the forecast period.
The hormone replacement therapy market is expected to be valued at US$ 14.82 billion in 2031.
The hormone replacement therapy market was valued at US$ 8.46 billion in 2023.
The List of Companies - Hormone Replacement Therapy Market
- Astrazeneca
- Pfizer Inc.
- Novartis AG
- Abbott
- Tolmar Inc
- Par Pharmaceutical
- Mayne Pharma Group Limited
- Novo Nordisk A/S
- Eli Lily And Company
- Noven Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.